Clinical Trials Browser

Phase EARLY_PHASE1 × OTHER × Epilepsy × Clear all

NCT05029960 2024-08-09

Tolerability and Activity of Brivaracetam (BRV) in Patients With Diffuse Gliomas

Phase EARLY_PHASE1 Active not recruiting

Brain Neoplasms, Epilepsy